Qiagen Said to Weigh Strategic Options Amid Fresh Interest (2)

Qiagen NV, the European molecular testing firm, is weighing strategic options including a potential sale amid fresh takeover interest, people with knowledge of the matter said.

The company is working with advisers as its supervisory board fields preliminary interest from potential suitors, the people said, asking not to be identified because the information is private. Qiagen has held talks with several possible buyers in recent weeks, including some US strategics, according to the people.

The stock soared as much as 7% in early Frankfurt trading to the highest level in almost a year, taking the company’s market value to ...